Management of Splenic Trauma in Contemporary Clinical Practice: A National Trauma Data Bank Study.


Journal

Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159

Informations de publication

Date de publication:
11 2021
Historique:
received: 01 08 2020
revised: 11 11 2020
accepted: 12 11 2020
pubmed: 9 12 2020
medline: 24 11 2021
entrez: 8 12 2020
Statut: ppublish

Résumé

To evaluate the utilization and efficacy of various treatments for management of adult patients with splenic trauma, highlighting the evolving role of splenic artery embolization. The National Trauma Data Bank (NTDB) was queried for patients who sustained splenic trauma between 2007 and 2015, excluding those with death on arrival and selected nonsplenic high-grade injuries. Patients were categorized into (1) nonoperative management (NOM), (2) embolization, (3) splenectomy, (4) splenic repair, and (5) combined treatment groups. Evaluated outcomes included hospital length of stay (LOS), intensive care unit LOS, mortality, and NOM and embolization failures. Overall, 117,743 patients with splenic predominant trauma were included in this study. Over the 9-year study period, 85,793 (72.9%) were treated with NOM, 21,999 (18.9%) with splenectomy, 3895 (3.3%) with embolization, and 2131 (1.8%) with splenic repair. From 2007 to 2015, mortality rates declined from 7.6% to 4.7%. The rate of NOM did not significantly change over time, while embolization increased 369% (1.3%-4.8%). Failure of NOM was 4.4% in 2007 and decreased to 3.4% in 2015. Across all injury grades, NOM had the shortest LOS (8.3 days), followed by splenic repair (12.3), embolization (12.6), and splenectomy (13.8) (p < 0.001). When adjusted for various clinical factors including severity of splenic injury, mortality rates were 7.1% for splenectomy, 3.2% for embolization, and 2.5% for NOM. Most patients with splenic-dominant blunt trauma are managed with NOM. Over time, the use of embolization has increased while open surgery has declined, and mortality has improved for all treatment methods. Compared to splenectomy, embolization is associated with shorter hospital LOS but is still used relatively infrequently.

Sections du résumé

BACKGROUND
To evaluate the utilization and efficacy of various treatments for management of adult patients with splenic trauma, highlighting the evolving role of splenic artery embolization.
MATERIALS AND METHODS
The National Trauma Data Bank (NTDB) was queried for patients who sustained splenic trauma between 2007 and 2015, excluding those with death on arrival and selected nonsplenic high-grade injuries. Patients were categorized into (1) nonoperative management (NOM), (2) embolization, (3) splenectomy, (4) splenic repair, and (5) combined treatment groups. Evaluated outcomes included hospital length of stay (LOS), intensive care unit LOS, mortality, and NOM and embolization failures.
RESULTS
Overall, 117,743 patients with splenic predominant trauma were included in this study. Over the 9-year study period, 85,793 (72.9%) were treated with NOM, 21,999 (18.9%) with splenectomy, 3895 (3.3%) with embolization, and 2131 (1.8%) with splenic repair. From 2007 to 2015, mortality rates declined from 7.6% to 4.7%. The rate of NOM did not significantly change over time, while embolization increased 369% (1.3%-4.8%). Failure of NOM was 4.4% in 2007 and decreased to 3.4% in 2015. Across all injury grades, NOM had the shortest LOS (8.3 days), followed by splenic repair (12.3), embolization (12.6), and splenectomy (13.8) (p < 0.001). When adjusted for various clinical factors including severity of splenic injury, mortality rates were 7.1% for splenectomy, 3.2% for embolization, and 2.5% for NOM.
CONCLUSION
Most patients with splenic-dominant blunt trauma are managed with NOM. Over time, the use of embolization has increased while open surgery has declined, and mortality has improved for all treatment methods. Compared to splenectomy, embolization is associated with shorter hospital LOS but is still used relatively infrequently.

Identifiants

pubmed: 33288400
pii: S1076-6332(20)30645-0
doi: 10.1016/j.acra.2020.11.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S138-S147

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Amanda H Chahine (AH)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Shenise Gilyard (S)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Tarek N Hanna (TN)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Sijian Fan (S)

Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Benjamin Risk (B)

Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Jamlik Omari Johnson (JO)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Richard Duszak (R)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Janice Newsome (J)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308.

Minzhi Xing (M)

Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Nima Kokabi (N)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, 550 Peachtree Street NE, Atlanta, GA 30308. Electronic address: nkokabi@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH